newsfilter
← Latest News
GlobeNewswire·

Athira Pharma Announces Last Patient Completed LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer's Disease

Reporting of Topline Results Targeted by End of Third Quarter 2024 Results to be presented in oral presentation at Clinical Trials on Alzheimer's Disease (CTAD) on October 29, 2024, in Madrid, Spain BOTHELL, Wash.,